12,879 Shares in Merck KGaA $MKGAF Bought by Pingora Partners LLC

Pingora Partners LLC acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAFFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 12,879 shares of the company’s stock, valued at approximately $1,655,000. Merck KGaA makes up approximately 1.0% of Pingora Partners LLC’s investment portfolio, making the stock its 29th biggest holding.

A number of other large investors have also added to or reduced their stakes in the company. Artia Global Partners LP bought a new position in Merck KGaA in the second quarter worth about $6,001,000. Ausdal Financial Partners Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter valued at about $3,076,000. Bamco Inc. NY purchased a new position in shares of Merck KGaA in the 2nd quarter worth approximately $2,827,000. Bank of America Corp DE bought a new position in shares of Merck KGaA during the 2nd quarter worth approximately $3,923,774,000. Finally, Blodgett Wealth Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at approximately $1,199,000. 0.10% of the stock is currently owned by institutional investors.

Merck KGaA Price Performance

Shares of MKGAF opened at $164.58 on Thursday. The company has a 50 day moving average of $163.19 and a two-hundred day moving average of $148.83. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a market cap of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96.

About Merck KGaA

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Featured Stories

Institutional Ownership by Quarter for Merck KGaA (OTCMKTS:MKGAF)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.